The company fought off association with poor performing IPOs from the same sector, which continues to suffer from Chinas melamine scandal. Biostime instead emphasised its European production lines, its well known brand in China and its growth potential in the sector."The company really focused on its brand ...
The rest of this content is available to subscribers and active trials only
Contact Jeremy Masters to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please call Jeremy Master on +44 (0)20 7779 8036 or email email@example.com to discuss your requirements.